Dr. Andrew Beharry's project focuses on developing a fluorescent photosensitizer that enables real-time imaging and targeted destruction of low-grade gliomas during surgery, helping surgeons better distinguish tumour tissue from healthy brain to improve outcomes and reduce recurrence.